PharmaQo Oxydrol 50 is a pharmaceutical-grade injectable containing 50 mg/mL Oxymetholone, a potent anabolic compound studied in investigational settings for severe anemia, tissue-wasting disorders, and nitrogen retention research.
While traditionally available as an oral formulation, the injectable version allows researchers to explore bypassing first-pass metabolism and evaluating pharmacokinetic differences in controlled studies.
Product Details:
Active Ingredient:
-
Oxymetholone (Anadrol)
Concentration: 50 mg/mL
Form: Injectable solution (intramuscular)
Vial Size: 10 mL multidose vial
Pharmacokinetics:
Injectable oxymetholone has an approximate half-life of 8–12 hours, requiring daily or alternate-day administration in research protocols.
Usage Recommendations:
-
Indications (Research Context): Investigational use for severe anemia models, muscle-wasting conditions, and nitrogen balance studies (not approved for human therapeutic use)
-
Typical Dosage (Research Use): 50–100 mg per day, depending on protocol
-
Monitoring: Liver function (due to methylated structure), lipid profile, androgenic effects, cardiovascular health
-
Cycle/Duration: Typically 4–6 weeks in research settings
Disclaimer:
This product is intended strictly for research and educational purposes. It is not for human consumption or therapeutic use. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with medical risks. Always comply with local research laws and ethical guidelines.
